Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure-Reference-Cited by-同舟云学术

Current Best Practice in Hepatitis B Management and Understanding Long-term Prospects for Cure

Published:2023-01 Issue:1 Volume:164 Page:42-60.e6
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Yardeni David,Chang Kyong-Mi,Ghany Marc G.^ORCID

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference156 articles.

1. Ten millennia of hepatitis B virus evolution;Kocher;Science,2021

2. Origins and evolution of the primate hepatitis B virus;Locarnini;Front Microbiol,2021

3. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study;Lancet Gastroenterol Hepatol,2018

4. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

5. World Health Organization. Hepatitis B key facts. Available at: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed January 21, 2022.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Higher BST2 Expression Promotes the Anti‐HBV Effect of IFN‐α and BST2 Genetic Variant Predicts PegIFNα Treatment Response of HBeAg‐Positive Chronic Hepatitis B Patients;Clinical Pharmacology & Therapeutics;2023-12-13

2. Interpreting Serogical Markers in Hepatitis B Virus Infection;Infectious Diseases in Clinical Practice;2023-10-31

3. Symptoms of Liver Disease During Tenofovir Therapy With or Without Peginterferon: Results from the Hepatitis B Research Network Immune Active Trial;Digestive Diseases and Sciences;2023-10-07

4. Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus;Journal of Medicinal Chemistry;2023-10-06

5. HBV precore G1896A mutation promotes growth of hepatocellular carcinoma cells by activating ERK/MAPK pathway;Virologica Sinica;2023-10